Works in Diabetes & Metabolism Journal, 2023, Vol 47, Issue 6


Results: 17
    1
    2
    3
    4
    5
    6
    7
    8

    The Efficacy and Safety of Moderate-Intensity Rosuvastatin with Ezetimibe versus High-Intensity Rosuvastatin in High Atherosclerotic Cardiovascular Disease Risk Patients with Type 2 Diabetes Mellitus: A Randomized, Multicenter, Open, Parallel, Phase 4 Study

    Published in:
    Diabetes & Metabolism Journal, 2023, v. 47, n. 6, p. 818, doi. 10.4093/dmj.2023.0171
    By:
    • Jun Sung Moon;
    • Il Rae Park;
    • Sang Soo Kim;
    • Hye Soon Kim;
    • Nam Hoon Kim;
    • Sin Gon Kim;
    • Seung Hyun Ko;
    • Ji Hyun Lee;
    • Inkyu Lee;
    • Bo Kyeong Lee;
    • Kyu Chang Won
    Publication type:
    Article
    9

    Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extension

    Published in:
    Diabetes & Metabolism Journal, 2023, v. 47, n. 6, p. 808, doi. 10.4093/dmj.2022.0387
    By:
    • Jun Sung Moon;
    • Il Rae Park;
    • Hae Jin Kim;
    • Choon Hee Chung;
    • Kyu Chang Won;
    • Kyung Ah Han;
    • Cheol-Young Park;
    • Jong Chul Won;
    • Dong Jun Kim;
    • Gwan Pyo Koh;
    • Eun Sook Kim;
    • Jae Myung Yu;
    • Eun-Gyoung Hong;
    • Chang Beom Lee;
    • Kun-Ho Yoon
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17